Oxygen Biotherapeutics Inc (NASDAQ:OXBT)
| 2.76 Data as of Jun 18 |  +0.07 / +2.60%Today’s Change | 2.53 Today|||52-Week Range 34.80 | -78.58% Year-to-Date |
Latest OXBT News | Press Releases
No recent news for Oxygen Biotherapeutics Inc.
Today’s Trading
| Previous close | 2.69 |
| Today’s open | 2.73 |
| Day’s range | -- - -- |
| Volume | 41,662 |
| Average volume (3 months) | 9,338 |
| Market cap | $7.2M |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -68.82% |
| P/E ratio | NM |
| Price/Sales | 459.14 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OXGNOXiGENE Inc | 0.00 | 0.00% |
| --EnzymeBioSystems | 0.00 | 0.00% |
| --Alternative Energy A... | 0.00 | 0.00% |
| CBMXCombiMatrix Corp | +0.41 | +16.14% |
Data as of 3:59pm ET, 06/18/2013
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $100.5K |
| Annual profit (last year) | -$15.7M |
| Net profit margin | -15,631.28% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive & Financial Officer Michael B. Jebsen, CPA |
Executive Vice President- Clinical Development Timothy Bradshaw, PhD |
Corporate headquarters Morrisville, North Carolina |
Forecasts
